{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:39:10Z","timestamp":1773661150274,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.thromres.2011.11.020","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T05:07:38Z","timestamp":1323407258000},"page":"341-344","source":"Crossref","is-referenced-by-count":22,"title":["Aspirin Resistance, Platelet Turnover, and Diabetic Angiopathy: A 2011 Update"],"prefix":"10.1016","volume":"129","author":[{"given":"Matteo Nicola Dario","family":"Di Minno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Lupoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola Macarone","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Russolillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Buonauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2011.11.020_bb0005","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood.V59.3.563.563","article-title":"Stored human platelets full aggregation potential in response to pairs of aggregating agents","volume":"59","author":"Di Minno","year":"1982","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2011.11.020_bb0245","doi-asserted-by":"crossref","first-page":"109e12","DOI":"10.1111\/j.1365-2141.1980.tb01189.x","article-title":"Positive interaction between agonists in the aggregation response of human blood platelets: interaction between ADP, adrenaline and vasopressin","volume":"44","author":"Grant","year":"1980","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.thromres.2011.11.020_bb0250","first-page":"57e60","article-title":"Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol","volume":"225","author":"Di Minno","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.thromres.2011.11.020_bb0255","doi-asserted-by":"crossref","first-page":"1081e5","DOI":"10.1182\/blood.V61.6.1081.1081","article-title":"Monitoring the entry of new platelets into the circulation after ingestion of aspirin","volume":"61","author":"Di Minno","year":"1983","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2011.11.020_bb0260","doi-asserted-by":"crossref","first-page":"1185e93","DOI":"10.1161\/01.CIR.72.6.1185","article-title":"Pharmacology of platelet inhibition in humans: implications of the salicylateaspirin interaction","volume":"72","author":"de Gaetano","year":"1985","journal-title":"Circulation"},{"issue":"7546","key":"10.1016\/j.thromres.2011.11.020_bb0265","first-page":"779e83","article-title":"Effects of salicylates on human platelets","volume":"1(","author":"O'Brien","year":"1968","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.thromres.2011.11.020_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.1980.tb05994.x","article-title":"Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats","volume":"46","author":"Dejana","year":"1980","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2011.11.020_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ajh.2830110404","article-title":"Epinephrine potentiation of arachidonateinduced aggregation of cyclooxygenase-deficient platelets","volume":"11","author":"Rao","year":"1981","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2011.11.020_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2007-1002650","article-title":"Large platelets circulate in an activated state in diabetes mellitus","volume":"17","author":"Tschoepe","year":"1991","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2011.11.020_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0609.1993.tb00160.x","article-title":"Influence of aspirin on human megakaryocyte prostaglandin synthesis","volume":"50","author":"van Pampus","year":"1993","journal-title":"Eur J Haematol"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2011.11.020_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2362.1994.tb02424.x","article-title":"Platelet turnover in advanced diabetes","volume":"24","author":"Winocour","year":"1994","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.thromres.2011.11.020_bb0270","first-page":"886e91","article-title":"Trial of repeated low-dose aspirin in diabetic angiopathy","volume":"68","author":"Di Minno","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.11.020_bb0275","doi-asserted-by":"crossref","first-page":"2048e50","DOI":"10.1046\/j.1538-7836.2003.00354.x","article-title":"Aspirin resistance: a revival of platelet aggregation tests?","volume":"1","author":"de Gaetano","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.11.020_bb0280","first-page":"1620e2","article-title":"Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?","volume":"108","author":"Halushka","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.11.020_bb0285","doi-asserted-by":"crossref","first-page":"1710e3","DOI":"10.1046\/j.1538-7836.2003.00284.x","article-title":"Aspirin resistance: definition, mechanisms and clinical read-outs","volume":"1","author":"Patrono","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.11.020_bb0290","doi-asserted-by":"crossref","first-page":"51e8","DOI":"10.1023\/A:1022066305399","article-title":"Aspirin resistance and genetic polymorphisms","volume":"14","author":"Cambria-Kiely","year":"2002","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2011.11.020_bb0295","doi-asserted-by":"crossref","first-page":"122e30","DOI":"10.1067\/mcp.2003.1","article-title":"Genetic variation in cyclooxygenase 1: effects on response to aspirin","volume":"73","author":"Halushka","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.thromres.2011.11.020_bb0300","doi-asserted-by":"crossref","first-page":"1122e6","DOI":"10.1016\/j.jacc.2003.08.062","article-title":"Inhibition of platelet aggregation by aspirin progressively decrease in long-term treated patients","volume":"43","author":"Pulcinelli","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.thromres.2011.11.020_bb0095","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.numecd.2011.04.002","article-title":"Aspirin resistance and platelet turnover: A 25-year old issue","volume":"21","author":"Di Minno","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.thromres.2011.11.020_bb0305","doi-asserted-by":"crossref","first-page":"27A","DOI":"10.1016\/j.amjcard.2008.11.020","article-title":"Variability in responsiveness to oral antiplatelet therapy","volume":"103","author":"Angiolillo","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2011.11.020_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201dand risk of cardiovascular morbidity: a systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2011.11.020_bb0310","doi-asserted-by":"crossref","first-page":"961e5","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.thromres.2011.11.020_bb0115","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1160\/TH08-03-0130","article-title":"PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients","volume":"99","author":"Crescente","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.11.020_bb0315","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/hrt.2005.079673","article-title":"DESCARTES Investigators. Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry","volume":"92","author":"Heras","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2011.11.020_bb0125","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/eurheartj\/ehn562","volume":"30","author":"Kuliczkowski","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2011.11.020_bb0130","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.thromres.2011.11.020_bb0320","doi-asserted-by":"crossref","first-page":"784.e1-6","DOI":"10.1016\/j.ahj.2009.08.013","article-title":"The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy","volume":"158","author":"Singla","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2011.11.020_bb0140","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.2337\/db07-0707","article-title":"The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study","volume":"56","author":"DiChiara","year":"2007","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.thromres.2011.11.020_bb0325","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/07853890.2011.582137","article-title":"Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention","volume":"43","author":"Di Minno","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.thromres.2011.11.020_bb0330","doi-asserted-by":"crossref","first-page":"1650e5","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.11.020_bb0155","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1538-7836.2004.00836.x","article-title":"Dav\u0131` G. Platelet activation in type 2 diabetes mellitus","volume":"2","author":"Ferroni","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.11.020_bb0335","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199006213222503","article-title":"Thromboxane biosynthesis and platelet function in type II diabetes mellitus","volume":"322","author":"Dav\u0131`","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.11.020_bb0340","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative metaanalysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.11.020_bb0170","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1111\/j.1538-7836.2005.01555.x","article-title":"Cycloxygenase-1 haplotype modulates platelet response to aspirin","volume":"3","author":"Maree","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.11.020_bb0345","doi-asserted-by":"crossref","first-page":"7634e9","DOI":"10.1073\/pnas.112202999","article-title":"Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets","volume":"99","author":"Rocca","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2011.11.020_bb0180","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(99)00498-5","article-title":"Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance","volume":"353","author":"Weber","year":"1999","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.thromres.2011.11.020_bb0185","first-page":"S42","article-title":"Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus","volume":"57","author":"Watala","year":"2005","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.thromres.2011.11.020_bb0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.11.020_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2004.02.017","article-title":"Aspirin resistance and diabetic angiopathy: back to the future","volume":"113","author":"Di Minno","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.11.020_bb0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00109-004-0600-x","article-title":"Increased protein glycation in diabetes mellitus is associated with decreased aspirin- mediated protein acetylation and reduced sensitivity of blood platelets to aspirin","volume":"83","author":"Watala","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.thromres.2011.11.020_bb0350","doi-asserted-by":"crossref","first-page":"723e7","DOI":"10.1016\/j.amjmed.2005.03.041","article-title":"Low-dose aspirin increases aspirin resistance in patients with coronary artery disease","volume":"118","author":"Lee","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2011.11.020_bb0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11739-010-0440-3","article-title":"TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus","volume":"6","author":"Santilli","year":"2011","journal-title":"Intern Emerg Med"},{"issue":"7","key":"10.1016\/j.thromres.2011.11.020_bb0360","doi-asserted-by":"crossref","DOI":"10.2165\/11536000-000000000-00000","article-title":"Antiplatelet drugs-do we need new options? With a reappraisal of direct thromboxane inhibitors","volume":"70","author":"Coccheri","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.thromres.2011.11.020_bb0365","first-page":"185e91","article-title":"Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease","volume":"9","author":"Grove","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.11.020_bb0225","unstructured":"W\u00fcrtz M, Wulff LN, Grove EL, Kristensen SD, Hvas AM. Influence of renal function and platelet turnover on the antiplatelet effect of aspirin. Thromb Res 2011 Aug 10 [Electronic publication ahead of print]."},{"issue":"5","key":"10.1016\/j.thromres.2011.11.020_bb0370","first-page":"316e8","article-title":"Platelet-aggregation response to single or paired aggregating stimuli after low-dose aspirin","volume":"314","author":"Cerletti","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.11.020_bb0235","doi-asserted-by":"crossref","unstructured":"Russolillo A, Di Minno MN, Tufano A, Prisco D, Di Minno G. Filling the gap between science & clinical practice: Prevention of stroke recurrence. Thromb Res 2011 Sep 8 [Electronic publication ahead of print].","DOI":"10.1016\/j.thromres.2011.08.012"},{"issue":"6","key":"10.1016\/j.thromres.2011.11.020_bb0240","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/157016111797484189","article-title":"New anti-thrombotic drugs for stroke prevention","volume":"9","author":"Di Minno","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.thromres.2011.11.020_bb0375","doi-asserted-by":"crossref","first-page":"5Be11B","DOI":"10.1016\/0002-9149(91)90379-Y","article-title":"Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists","volume":"68","author":"Fitzgerald","year":"1991","journal-title":"Am J Cardiol"},{"issue":"6618","key":"10.1016\/j.thromres.2011.11.020_bb0380","first-page":"320e31","article-title":"Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists\u2019 Collaboration","volume":"296","year":"1988","journal-title":"Br Med J"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811006141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811006141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T14:31:19Z","timestamp":1593354679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811006141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0049384811006141"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.11.020","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}